Havana Cuba Business Travel Culture and Politics

Havana Cuba News

Cuba Culture News

Posted November 02, 2004 by publisher in Cuban Healthcare

Email this article | Print this article | Search Havana Journal        

DTcuba.com

The Cuban-made synthetic vaccine against the Haemophilus influenzae type B, the first of its kind developed in the world, has been described as a relevant scientific breakthrough.

Experts who attended the 5th International Congress on Chemistry, held in Havana, highlighted the excellent quality of the Cuban vaccine, which was obtained from synthetic antigens.

The product, created by Dr. Vicente Verez, does not contain any component of the bacterium.

In practice, it is a reproduction of the structure of the molecule of the Haemophilus influenza type B, so that it can be recognized by the immune system.

The Cuban vaccine is highly effective to fight the bacterium, against which the body generates a defensive response.

From the industrial viewpoint, it is feasible to increase production of the vaccine, since it poses a lower chemical risk for human health.

Would you like to add more information?


Only members can add more information. Please register or log in

  • Advertise at Havana Journal Inc
Images of Cuba
Illustration of General Antonio Maceo
Follow Havana Journal
SUBSCRIBE to our Cuba Watch newsletter
LIKE us on Facebook

FOLLOW us on Twitter

CONNECT with us on Linked In

Section Archive
Havana Journal, Inc. BBB Business Review



Member of the Association for the Study of the Cuban Economy